UBS Group’s INmune Bio INMB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.04M | Buy |
|
|||||
|
2025
Q1 | $1.07M | Buy |
|
|||||
|
2024
Q4 | $636K | Buy |
|
|||||
|
2024
Q3 | $233K | Buy |
|
|||||
|
2024
Q2 | $355K | Buy |
|
|||||
|
2024
Q1 | $450K | Sell |
|
|||||
|
2023
Q4 | $487K | Buy |
|
|||||
|
2023
Q3 | $283K | Sell |
|
|||||
|
2023
Q2 | $474K | Sell |
|
|||||
|
2023
Q1 | $347K | Buy |
|
|||||
|
2022
Q4 | $285K | Buy |
|
|||||
|
2022
Q3 | $248K | Buy |
|
|||||
|
2022
Q2 | $344K | Buy |
|
|||||
|
2022
Q1 | $303K | Hold |
|
|||||
|
2021
Q4 | $367K | Buy |
|
|||||
|
2021
Q3 | $585K | Buy |
|
|||||
|
2021
Q2 | $131K | Buy |
|
|||||
|
2021
Q1 | $39K | Buy |
|
|||||
|
2020
Q4 | $4K | Buy |
|
|||||
|
2020
Q3 | – | Sell |
|
|||||
|
2020
Q2 | $4K | Sell |
|
|||||
|
2020
Q1 | $4K | Buy |
|
|||||
|
2019
Q4 | $0 | Sell |
|
|||||
|
2019
Q3 | $4K | Buy |
|
|||||
|
2019
Q2 | $2K | Sell |
|
|||||
|
2019
Q1 | $9K | Buy |
|